Barham W - Search Results

1

Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.

Wilson AJ, Saskowski J, Barham W, Yull F, Khabele D. Wilson AJ, et al. Among authors: barham w. J Ovarian Res. 2015 Jul 28;8:46. doi: 10.1186/s13048-015-0177-8. J Ovarian Res. 2015. PMID: 26215403 Free PMC article.

2

Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model.

Wilson AJ, Barham W, Saskowski J, Tikhomirov O, Chen L, Lee HJ, Yull F, Khabele D. Wilson AJ, et al. Among authors: barham w. J Ovarian Res. 2013 Sep 10;6(1):63. doi: 10.1186/1757-2215-6-63. J Ovarian Res. 2013. PMID: 24020521 Free PMC article.

3

Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer.

Wilson AJ, Saskowski J, Barham W, Khabele D, Yull F. Wilson AJ, et al. Among authors: barham w. Mol Cancer. 2015 Nov 9;14:192. doi: 10.1186/s12943-015-0463-5. Mol Cancer. 2015. PMID: 26552746 Free PMC article.

4

Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer.

Hoover AA, Hufnagel DH, Harris W, Bullock K, Glass EB, Liu E, Barham W, Crispens MA, Khabele D, Giorgio TD, Wilson AJ, Yull FE. Hoover AA, et al. Among authors: barham w. BMC Cancer. 2020 Oct 7;20(1):970. doi: 10.1186/s12885-020-07450-8. BMC Cancer. 2020. PMID: 33028251 Free PMC article.

5

Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden.

Connelly L, Barham W, Onishko HM, Sherrill T, Chodosh LA, Blackwell TS, Yull FE. Connelly L, et al. Among authors: barham w. Oncogene. 2011 Mar 24;30(12):1402-12. doi: 10.1038/onc.2010.521. Epub 2010 Nov 15. Oncogene. 2011. PMID: 21076466 Free PMC article.

6

Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection.

Connelly L, Barham W, Pigg R, Saint-Jean L, Sherrill T, Cheng DS, Chodosh LA, Blackwell TS, Yull FE. Connelly L, et al. Among authors: barham w. J Cell Physiol. 2010 Jan;222(1):73-81. doi: 10.1002/jcp.21922. J Cell Physiol. 2010. PMID: 19746431 Free PMC article.

7

NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model.

Connelly L, Barham W, Onishko HM, Chen L, Sherrill TP, Zabuawala T, Ostrowski MC, Blackwell TS, Yull FE. Connelly L, et al. Among authors: barham w. Breast Cancer Res. 2011 Aug 31;13(4):R83. doi: 10.1186/bcr2935. Breast Cancer Res. 2011. PMID: 21884585 Free PMC article.

8

Intraductal injection of LPS as a mouse model of mastitis: signaling visualized via an NF-κB reporter transgenic.

Barham W, Sherrill T, Connelly L, Blackwell TS, Yull FE. Barham W, et al. J Vis Exp. 2012 Sep 4;(67):e4030. doi: 10.3791/4030. J Vis Exp. 2012. PMID: 22971993 Free PMC article.

9

Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions.

Ortega RA, Barham W, Sharman K, Tikhomirov O, Giorgio TD, Yull FE. Ortega RA, et al. Among authors: barham w. Int J Nanomedicine. 2016 May 18;11:2163-77. doi: 10.2147/IJN.S93483. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27274241 Free PMC article.

10

Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages.

Ortega RA, Barham WJ, Kumar B, Tikhomirov O, McFadden ID, Yull FE, Giorgio TD. Ortega RA, et al. Nanoscale. 2015 Jan 14;7(2):500-10. doi: 10.1039/c4nr03962a. Nanoscale. 2015. PMID: 25408159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters